Liver Tumors in Pediatric Patients
The most recent advance in the care of children diagnosed with hepatoblastoma and hepatocellular carcinoma is the Pediatric Hepatic International Tumor Trial, which opened to international enrollment in 2018. It is being conducted as a collaborative effort by the pediatric multicenter trial groups in North America, Europe, and the Far East. This international effort was catalyzed by a new unified global risk stratification system for hepatoblastoma, an international histopathologic consensus classification for pediatric liver tumors, and a revised 2017 collaborative update of the PRE-Treatment EXTent of disease radiographic based staging system.
Source: Surgical Oncology Clinics of North America - Category: Surgery Authors: Rebecka Meyers, Eiso Hiyama, Piotr Czauderna, Greg M. Tiao Source Type: research
More News: Cancer & Oncology | Carcinoma | Children | Hepatoblastoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Pediatrics | Radiography | Surgery | Urology & Nephrology